Neisseria sicca and Corynebacterium matruchotii inhibited oral squamous cell carcinomas by regulating genome stability

References

• Chinn SB, Myers JN. Oral cavity carcinoma: current management, controversies, and future directions. J Clin Oncol. 2015;33(29):3269–3276.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
   PubMed Web of Science ®Google Scholar
• Kamarajan P, Ateia I, Shin JM, et al. Periodontal pathogens promote cancer aggressivity via TLR/MyD88 triggered activation of Integrin/FAK signaling that is therapeutically reversible by a probiotic bacteriocin. PLoS Pathog. 2020;16:e1008881.
   PubMed Web of Science ®Google Scholar
• Wen L, et al.$3$2 2020. Porphyromonas gingivalis Promotes Oral Squamous Cell Carcinoma Progression in an Immune Microenvironment. J Dent Res. 99(6):666–675. doi:10.1177/0022034520909312.
   PubMed Web of Science ®Google Scholar
• La Rosa GRM, Gattuso G, Pedullà E, et al. Association of oral dysbiosis with oral cancer development. Oncol Lett. 2020;19:3045–3058.
   PubMed Web of Science ®Google Scholar
• Asoudeh-Fard A, Barzegari A, Dehnad A, et al. Lactobacillus plantarum induces apoptosis in oral cancer KB cells through upregulation of PTEN and downregulation of MAPK signalling pathways. Bioimpacts. 2017;7:193–198.
   PubMed Web of Science ®Google Scholar
• Bernardes N, Seruca R, Chakrabarty AM, et al. Microbial-based therapy of cancer: current progress and future prospects. Bioeng Bugs. 2010;1:178–190.
   PubMedGoogle Scholar
• Lindemann A, Takahashi H, Patel AA, et al. Targeting the DNA damage response in OSCC with TP53 mutations. J Dent Res. 2018;97:635–644.
   PubMed Web of Science ®Google Scholar
• Nwizu N, Wactawski-Wende J, Genco RJ. Periodontal disease and cancer: epidemiologic studies and possible mechanisms. Periodontol 2000. 2020;83:213–233.
   PubMed Web of Science ®Google Scholar
• Healy CM, Moran GP. The microbiome and oral cancer: more questions than answers. Oral Oncol. 2019;89:30–33.
   PubMed Web of Science ®Google Scholar
• Li Y, He J, He Z, et al. Phylogenetic and functional gene structure shifts of the oral microbiomes in periodontitis patients. ISME J. 2014;8:1879–1891.
   PubMed Web of Science ®Google Scholar
• Garrett WS. Cancer and the microbiota. Science. 2015;348:80–86.
   PubMed Web of Science ®Google Scholar
• Jeggo PA, Pearl LH, Carr AM. DNA repair, genome stability and cancer: a historical perspective. Nat Rev Cancer. 2016;16:35–42.
   PubMed Web of Science ®Google Scholar
• Williams AB, Schumacher B. p53 in the DNA-damage-repair process. Cold Spring Harb Perspect Med. 2016;6:a026070.
   PubMed Web of Science ®Google Scholar
• Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature. 2009;461:1071–1078.
   PubMed Web of Science ®Google Scholar
• Krishnan V, Lim DXE, Hoang PM, et al. DNA damage signalling as an anti-cancer barrier in gastric intestinal metaplasia. Gut. 2020;69:1738–1749.
   PubMed Web of Science ®Google Scholar
• Campisi J, D’adda Di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol. 2007;8:729–740.
   PubMed Web of Science ®Google Scholar
• Halazonetis TD, Gorgoulis VG, Bartek J. An oncogene-induced DNA damage model for cancer development. Science. 2008;319:1352–1355.
   PubMed Web of Science ®Google Scholar
• Zhou R, Yazdi AS, Menu P, et al. A role for mitochondria in NLRP3 inflammasome activation. Nature. 2011;469:221–225.
   PubMed Web of Science ®Google Scholar
• Srinivas US, Tan BWQ, Vellayappan BA, et al. ROS and the DNA damage response in cancer. Redox Biol. 2019;25:101084.
   PubMed Web of Science ®Google Scholar
• Mangan MSJ, Olhava EJ, Roush WR, et al. Targeting the NLRP3 inflammasome in inflammatory diseases. Nat Rev Drug Discov. 2018;17:588–606.
   PubMed Web of Science ®Google Scholar
• Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140:805–820.
   PubMed Web of Science ®Google Scholar
• Shi J, Zhao Y, Wang K, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015;526:660–665.
   PubMed Web of Science ®Google Scholar
• Tang R, Xu J, Zhang B, et al. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity. J Hematol Oncol. 2020;13:110.
   PubMed Web of Science ®Google Scholar
• Wei Q, Zhu R, Zhu J, et al. E2-induced activation of the NLRP3 inflammasome triggers pyroptosis and inhibits autophagy in HCC cells. Oncol Res. 2019;27:827–834.
   PubMed Web of Science ®Google Scholar
• Grilli DJ, Mansilla ME, Giménez MC, et al. Pseudobutyrivibrio xylanivorans adhesion to epithelial cells. Anaerobe. 2019;56:1–7.
   PubMed Web of Science ®Google Scholar
• Han YW, Shi W, Huang GT, et al. Interactions between periodontal bacteria and human oral epithelial cells: Fusobacterium nucleatum adheres to and invades epithelial cells. Infect Immun. 2000;68:3140–3146.
   PubMed Web of Science ®Google Scholar
• Simon DW, Rogers MB, Gao Y, et al. Depletion of gut microbiota is associated with improved neurologic outcome following traumatic brain injury. Brain Res. 2020;1747:147056.
   PubMed Web of Science ®Google Scholar
• Binder Gallimidi A, Fischman S, Revach B, et al. Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model. Oncotarget. 2015;6:22613–22623.
   PubMedGoogle Scholar
• Zhao X, Yang C-X, Chen L-G, et al. Dual-stimuli responsive and reversibly activatable theranostic nanoprobe for precision tumor-targeting and fluorescence-guided photothermal therapy. Nat Commun. 2017;8:14998.
   PubMed Web of Science ®Google Scholar
• Peng Q-S, Cheng Y-N, Zhang W-B, et al. circRNA_0000140 suppresses oral squamous cell carcinoma growth and metastasis by targeting miR-31 to inhibit hippo signaling pathway. Cell Death Dis. 2020;11:112.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Yang T, Yan Y, et al. Alterations of oral microbiota in Chinese patients with esophageal cancer. Front Cell Infect Microbiol. 2020;10:541144.
   PubMed Web of Science ®Google Scholar
• Chen X, Winckler B, Lu M, et al. Oral microbiota and risk for esophageal squamous cell carcinoma in a high-risk area of China. PLoS One. 2015;10:e0143603.
   PubMed Web of Science ®Google Scholar
• Hayes RB, Ahn J, Fan X, et al. Association of oral microbiome with risk for incident head and neck squamous cell cancer. JAMA Oncol. 2018;4:358–365.
   PubMed Web of Science ®Google Scholar
• Baraniya D, Jain V, Lucarelli R, et al. Screening of health-associated oral bacteria for anticancer properties in vitro. Front Cell Infect Microbiol. 2020;10:575656.
   PubMed Web of Science ®Google Scholar
• Tchakarska G, Sola B. The double dealing of cyclin D1. Cell Cycle. 2020;19:163–178.
   PubMed Web of Science ®Google Scholar
• Zainal NS, Lee BKB, Wong ZW, et al. Effects of palbociclib on oral squamous cell carcinoma and the role of PIK3CA in conferring resistance. Cancer Biol Med. 2019;16:264–275.
   PubMed Web of Science ®Google Scholar
• Arora R, Bharti V, Gaur P, et al. Operculina turpethum extract inhibits growth and proliferation by inhibiting NF-κB, COX-2 and cyclin D1 and induces apoptosis by up regulating P53 in oral cancer cells. Arch Oral Biol. 2017;80:1–9.
   PubMed Web of Science ®Google Scholar
• Zheng M, Williams EP, Malireddi RKS, et al. Impaired NLRP3 inflammasome activation/pyroptosis leads to robust inflammatory cell death via caspase-8/RIPK3 during coronavirus infection. J Biol Chem. 2020;295:14040–14052.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhang Y, Xia S, et al. Gasdermin E suppresses tumour growth by activating anti-tumour immunity. Nature. 2020;579:415–420.
   PubMed Web of Science ®Google Scholar
• Wang Q, Wang Y, Ding J, et al. A bioorthogonal system reveals antitumour immune function of pyroptosis. Nature. 2020;579:421–426.
   PubMed Web of Science ®Google Scholar
• Dunn JH, Ellis LZ, Fujita M. Inflammasomes as molecular mediators of inflammation and cancer: potential role in melanoma. Cancer Lett. 2012;314:24–33.
   PubMed Web of Science ®Google Scholar
• Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity. 2019;51:27–41.
   PubMed Web of Science ®Google Scholar
• Lin J, Guan Z, Wang C, et al. Inhibitor of differentiation 1 contributes to head and neck squamous cell carcinoma survival via the NF-kappaB/survivin and phosphoinositide 3-kinase/Akt signaling pathways. Clin Cancer Res. 2010;16:77–87.
   PubMed Web of Science ®Google Scholar
• Wu J, Hong Y, Wu T, et al. Stromal-epithelial lactate shuttle induced by tumor‑derived interleukin‑1β promotes cell proliferation in oral squamous cell carcinoma. Int J Mol Med. 2018;41:687–696.
   PubMedGoogle Scholar
• Sun W, Guo MM, Han P, et al. Id-1 and the p65 subunit of NF-κB promote migration of nasopharyngeal carcinoma cells and are correlated with poor prognosis. Carcinogenesis. 2012;33:810–817.
   PubMed Web of Science ®Google Scholar
• Steel JL, Terhorst L, Collins KP, et al. Prospective analyses of cytokine mediation of sleep and survival in the context of advanced cancer. Psychosom Med. 2018;80:483–491.
   PubMed Web of Science ®Google Scholar
• Mantovani A, Barajon I, Garlanda C. IL-1 and IL-1 regulatory pathways in cancer progression and therapy. Immunol Rev. 2018;281:57–61.
   PubMed Web of Science ®Google Scholar
• Fisher DT, Appenheimer MM, Evans SS. The two faces of IL-6 in the tumor microenvironment. Semin Immunol. 2014;26:38–47.
   PubMed Web of Science ®Google Scholar
• Haque ASMR, Moriyama M, Kubota K, et al. CD206+ tumor-associated macrophages promote proliferation and invasion in oral squamous cell carcinoma via EGF production. Sci Rep. 2019;9:14611.
   PubMed Web of Science ®Google Scholar
• Borst J, Ahrends T, Bąbała N, et al. CD4(+) T cell help in cancer immunology and immunotherapy. Nat Rev Immunol. 2018;18:635–647.
   PubMed Web of Science ®Google Scholar
• Gaur P, Qadir GA, Upadhyay S, et al. Skewed immunological balance between Th17 (CD4(+)IL17A (+)) and Treg (CD4 (+)CD25 (+)FOXP3 (+)) cells in human oral squamous cell carcinoma. Cell Oncol (Dordr). 2012;35:335–343.
   PubMed Web of Science ®Google Scholar
• Shan Z, Liu S, Yang L, et al. Repertoire of peripheral T cells in patients with oral squamous cell carcinoma. Oral Dis. 2020;26:885–893.
   PubMed Web of Science ®Google Scholar